Although surfactant producing alveolar type 2 cells have been the focus for many years, the alveolar type 1 (AT1) cells are the neighboring lung epithelial cells that cover >90% gas exchange surface area. We found AT1 cells are more than a passive structure because they express VEGFA and signal to the vasculature. We also found AT1 cells express Wnt ligands. Interestingly, cultured lung fibroblasts proliferate upon WNT3A stimulation and lung myofibroblasts express widely canonical Wnt target gene, Axin2. This led to our hypothesis that AT1 cells signal lung myofibroblasts via Wnt ligands. We will investigate the requirement of AT1-derived Wnt ligands for lung myofibroblasts during alveologenesis (aim 1), the epithelial-mesenchymal signaling mechanism (aim 2), and the Wnt-mediated crosstalk between AT1 and lung myofibroblasts in an experimental BPD models (aim 3). Successful completion of this study will reveal a new signaling role of AT1 cells and elucidate lung mesenchymal cell types, thereby representing a first step toward our long-term goal of unraveling epithelial-mesenchymal crosstalk during alveologenesis and BPD pathogenesis.

Public Health Relevance

Alveolar type 1 (AT1) cells are traditionally considered a passive gas-exchanging structure that covers nearly all the lung surface area. Although research efforts in lung development and chronic diseases such as bronchopulmonary dysplasia and pulmonary fibrosis have focused mainly on the surfactant-producing alveolar type 2 cells, they have mostly left out the ?elephant in the room?, the AT1 cells. Using the latest technology, we found AT1 cells have novel signaling roles via Wnt ligands towards neighboring cells during alveologenesis, representing a new dimension of the canonical Wnt signaling pathway in lung development and disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
5F31HL149232-02
Application #
10063428
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Kalantari, Roya
Project Start
2019-09-01
Project End
2022-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Hospitals
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030